Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Helen Torley

Affiliations

  • Director at Quest Diagnostics Inc (DGX), 2019-05-16
  • President And Ceo at Halozyme Therapeutics Inc (HALO), 2019-02-23
  • Director at Relypsa Inc (RLYP), 2016-09-02
  • Evp, Chief Commercial Officer at Onyx Pharmaceuticals Inc (ONXX), 2013-10-04
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
HALO $8.92 50,000 Officer, Director 50,000 2014-09-16 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
RLYP $19.32 1,013 Director 1,237 2016-06-07 Filing
ONXX $126.93 1,061 Officer 46,585 2013-08-12 Filing
ONXX $126.89 8,250 Officer 47,646 2013-08-12 Filing
ONXX $97.26 1,000 Officer 47,646 2013-05-13 Filing
ONXX $98.28 2,500 Officer 48,646 2013-05-13 Filing